Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients

• Published in: Pediatric research 2022-08, Vol.92 (2), p.474-479
• Main Authors: Aktuglu Zeybek, Ayse Cigdem, Kiykim, Ertugrul, Neselioglu, Salim, Iscan, Halise Zeynep, Zubarioglu, Tanyel, Cansever, Mehmet Serif, Erel, Ozcan
• Format: Article
• Language: English
• Subjects: Carcinoma, Hepatocellular; Clinical Research Article; Cyclohexanones; Disulfides; Homeostasis; Homeostasis - physiology; Humans; Liver cancer; Liver Neoplasms; Medicine; Medicine & Public Health; Nitrobenzoates; Oxidative Stress; Pediatric Surgery; Pediatrics; Sulfhydryl Compounds; Tyrosine; Tyrosinemias - diagnosis; Tyrosinemias - drug therapy
• ISSN: 0031-3998; 1530-0447
• DOI: 10.1038/s41390-021-01770-6

Background Despite successful treatment with nitisinone, the pathophysiology of long-term complications, including hepatocellular carcinoma and mental decline in tyrosinemia type 1 patients, is still obscure. Oxidative stress may play a role in these complications. While increased fumarylacetoacetate and maleylacetoacetate cause oxidative stress in the liver, increased tyrosine causes oxidative stress in the brain. The aim of this study is to evaluate dynamic thiol/disulfide homeostasis as an indicator of oxidative stress in late-diagnosed tyrosinemia type 1 patients. Methods Twenty-four late-diagnosed (age of diagnosis; 14.43 ± 26.35 months) tyrosinemia type 1 patients (19 under nitisinone treatment and 5 with liver transplantation) and 25 healthy subjects were enrolled in the study. Serum native thiol, total thiol, and disulfide levels were measured, and disulfide/native, disulfide/total, and native thiol/total thiol ratios were calculated from these values. Results No significant difference was observed in native, total, and disulfide thiol levels between the groups and no increase in disulfide/native, disulfide/total, and native/total thiol ratios was detected, despite significantly higher plasma tyrosine levels in the nitisinone-treated group. Conclusions We suggest that providing sufficient metabolic control with good compliance to nitisinone treatment can help to prevent oxidative stress in late-diagnosed tyrosinemia type 1 patients. Impact Despite successful nitisinone (NTBC) treatment, the underlying mechanisms of long-term complications in hereditary tyrosinemia type 1 (HT1), including hepatocellular carcinoma and mental decline, are still obscure. Oxidative stress may play a role in these complications. Thiol/disulfide homeostasis, which is an indicator of oxidative stress, is not disturbed in hereditary tyrosinemia patients under NTBC treatment, despite higher plasma tyrosine levels and patients who had liver transplantation. This is the first study evaluating dynamic thiol/disulfide homeostasis as an indicator of oxidative stress in late-diagnosed HT1 patients.